231 related articles for article (PubMed ID: 24239264)
1. Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer.
Zhang L; Zhou F; ten Dijke P
Trends Biochem Sci; 2013 Dec; 38(12):612-20. PubMed ID: 24239264
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
Olieslagers S; Pardali E; Tchaikovski V; ten Dijke P; Waltenberger J
Cardiovasc Res; 2011 Aug; 91(3):510-8. PubMed ID: 21478266
[TBL] [Abstract][Full Text] [Related]
3. TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.
Hamidi A; Song J; Thakur N; Itoh S; Marcusson A; Bergh A; Heldin CH; Landström M
Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676490
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner.
Wygrecka M; Zakrzewicz D; Taborski B; Didiasova M; Kwapiszewska G; Preissner KT; Markart P
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):614-27. PubMed ID: 22771387
[TBL] [Abstract][Full Text] [Related]
5. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity.
Toulany M; Baumann M; Rodemann HP
Mol Cancer Res; 2007 Aug; 5(8):863-72. PubMed ID: 17699110
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers.
Michl P; Downward J
Z Gastroenterol; 2005 Oct; 43(10):1133-9. PubMed ID: 16220453
[TBL] [Abstract][Full Text] [Related]
7. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways.
Lin SJ; Chang C; Ng AK; Wang SH; Li JJ; Hu CP
Apoptosis; 2007 Sep; 12(9):1659-70. PubMed ID: 17624592
[TBL] [Abstract][Full Text] [Related]
8. Targeting phosphoinositide 3-kinase: moving towards therapy.
Marone R; Cmiljanovic V; Giese B; Wymann MP
Biochim Biophys Acta; 2008 Jan; 1784(1):159-85. PubMed ID: 17997386
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
[TBL] [Abstract][Full Text] [Related]
10. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
11. PKB/Akt-dependent regulation of cell motility.
Xue G; Hemmings BA
J Natl Cancer Inst; 2013 Mar; 105(6):393-404. PubMed ID: 23355761
[TBL] [Abstract][Full Text] [Related]
12. PI3K-Akt pathway: its functions and alterations in human cancer.
Osaki M; Oshimura M; Ito H
Apoptosis; 2004 Nov; 9(6):667-76. PubMed ID: 15505410
[TBL] [Abstract][Full Text] [Related]
13. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
14. PI3K/AKT signaling pathway and cancer: an updated review.
Martini M; De Santis MC; Braccini L; Gulluni F; Hirsch E
Ann Med; 2014 Sep; 46(6):372-83. PubMed ID: 24897931
[TBL] [Abstract][Full Text] [Related]
15. Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway.
Bian Y; Terse A; Du J; Hall B; Molinolo A; Zhang P; Chen W; Flanders KC; Gutkind JS; Wakefield LM; Kulkarni AB
Cancer Res; 2009 Jul; 69(14):5918-26. PubMed ID: 19584284
[TBL] [Abstract][Full Text] [Related]
16. The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer.
Assinder SJ; Dong Q; Kovacevic Z; Richardson DR
Biochem J; 2009 Jan; 417(2):411-21. PubMed ID: 19099539
[TBL] [Abstract][Full Text] [Related]
17. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.
Jung KH; Ryu YL; Lee HS; Lee H; Son MK; Yan HH; Hong SW; Ryu JK; Hong S; Suh JK; Hong SS
Int J Oncol; 2013 Jun; 42(6):2001-8. PubMed ID: 23588860
[TBL] [Abstract][Full Text] [Related]
18. PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancer.
Goc A; Al-Husein B; Kochuparambil ST; Liu J; Heston WW; Somanath PR
Int J Oncol; 2011 Jan; 38(1):267-77. PubMed ID: 21109949
[TBL] [Abstract][Full Text] [Related]
19. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
20. TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability.
Liu WT; Huang KY; Lu MC; Huang HL; Chen CY; Cheng YL; Yu HC; Liu SQ; Lai NS; Huang HB
Oncogene; 2017 May; 36(19):2715-2723. PubMed ID: 27893708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
